MountSinaiLiver(@MountSinaiLiver) 's Twitter Profileg
MountSinaiLiver

@MountSinaiLiver

Official account of the Division of Liver Diseases @MountSinaiNYC

ID:885259124543455232

linkhttp://www.mountsinai.org/patient-care/service-areas/liver-diseases calendar_today12-07-2017 22:06:37

667 Tweets

1,2K Followers

384 Following

Follow People
REACH Program(@REACHProgramNYC) 's Twitter Profile Photo

Hispanic Federation A3: Our community health workers and providers (some pictured here!) educate clients after they complete treatment on the risks of reinfection and the importance of continuing care if they have cirrhosis. We collaborate closely with the MountSinaiLiver

@HispanicFed A3: Our community health workers and providers (some pictured here!) educate clients after they complete #HCV treatment on the risks of reinfection and the importance of continuing care if they have cirrhosis. We collaborate closely with the @MountSinaiLiver #together #HepFreeNYC
account_circle
MountSinaiLiver(@MountSinaiLiver) 's Twitter Profile Photo

📌Mark your calendars! The Annual Fenton Schaffner Lectureship is coming up on May 22, 2024. Join us in honoring the phenomenal contributions of Dr. Schaffner to liver diseases. Followed by intellectual discourse, cocktails begin at 4pm. Don't miss out!

📌Mark your calendars! The Annual Fenton Schaffner Lectureship is coming up on May 22, 2024. Join us in honoring the phenomenal contributions of Dr. Schaffner to liver diseases. Followed by intellectual discourse, cocktails begin at 4pm. Don't miss out! #LiverDiseases
account_circle
MountSinaiLiver(@MountSinaiLiver) 's Twitter Profile Photo

Seeking a motivated post-doc to study novel mouse models of cholangiocarcinoma with KRASG12D mutations. Help us explore how KRAS impacts the immune response and therapy outcomes. Apply now: bit.ly/3vG5zg6 Mount Sinai Department of Medicine

Seeking a motivated post-doc to study novel mouse models of cholangiocarcinoma with KRASG12D mutations. Help us explore how KRAS impacts the immune response and therapy outcomes. Apply now: bit.ly/3vG5zg6 #CancerResearch #PostDocJobs #NYC #WeFindAWay @DOMSinaiNYC
account_circle
Ponni Perumalswami(@ponnivp) 's Twitter Profile Photo

Out now 💥 pragmatic RCT which found higher HCV cure rates with facilitated telemedicine integrated into opioid treatment programs led by Dr. Andrew Talal at UBuffalo. Proud to be part of this study. Michigan Hepatology MountSinaiLiver

account_circle
Mount Sinai Department of Medicine(@DOMSinaiNYC) 's Twitter Profile Photo

“When people hold your hand, when they smile, it makes all the difference in the world.” Watch Floyd’s story and share your own here before on March 30: giving.mountsinai.org/shareyourstory
MountSinaiLiver

youtube.com/watch?v=gnWcmB…

account_circle
MountSinaiLiver(@MountSinaiLiver) 's Twitter Profile Photo

Join us for the annual Fenton Schaffner Lectureship on May 22, 2024, honoring Dr. Fenton Schaffner's contributions to Liver Diseases at Mount Sinai. Cocktail at 4 pm, lectureship at 5 pm. This year's awardees: Dr. Norah Terrault presented by Dr. Meena Bansal.

Join us for the annual Fenton Schaffner Lectureship on May 22, 2024, honoring Dr. Fenton Schaffner's contributions to Liver Diseases at Mount Sinai. Cocktail at 4 pm, lectureship at 5 pm. This year's awardees: Dr. Norah Terrault presented by Dr. Meena Bansal.
account_circle
MountSinaiLiver(@MountSinaiLiver) 's Twitter Profile Photo

Join us for the annual Fenton Schaffner Lectureship on May 22, 2024, honoring Dr. Fenton Schaffner's contributions to Liver Diseases at Mount Sinai. Cocktail at 4 pm, lectureship at 5 pm. This year's awardees: Dr. Norah Terrault presented by Dr. Meena Bansal.

Join us for the annual Fenton Schaffner Lectureship on May 22, 2024, honoring Dr. Fenton Schaffner's contributions to Liver Diseases at Mount Sinai. Cocktail at 4 pm, lectureship at 5 pm. This year's awardees: Dr. Norah Terrault presented by Dr. Meena Bansal.
account_circle
Mount Sinai Department of Medicine(@DOMSinaiNYC) 's Twitter Profile Photo

Mount Sinai is proud to have contributed to all Resmetirom (Rezdiffra) clinical trials. Exciting news: approves the first treatment for patients with liver scarring due to .
Learn more bit.ly/48VhV1h

Mount Sinai is proud to have contributed to all Resmetirom (Rezdiffra) clinical trials. Exciting news: #FDA approves the first treatment for patients with liver scarring due to #FattyLiverDisease. Learn more bit.ly/48VhV1h #MASH #NASH #NYC #WeFindAWay
account_circle
Mount Sinai Department of Medicine(@DOMSinaiNYC) 's Twitter Profile Photo

.Dr. Tatyana Kushner, MD, discusses why it is important that once providers see patients who are at risk for, or living with viral , they conduct the appropriate testing and ensure that patients are linked to follow up care. MountSinaiLiver
healio.com/news/gastroent…

account_circle
Mount Sinai Department of Medicine(@DOMSinaiNYC) 's Twitter Profile Photo

Full article: bit.ly/41X7msx
There is a worldwide epidemic of stereotactic (fatty) liver disease that affects up to 35% of Americans. A subset of these patients (~20%) with steatotic liver disease progress to an inflammatory fibrotic condition known as metabolic…

Full article: bit.ly/41X7msx There is a worldwide epidemic of stereotactic (fatty) liver disease that affects up to 35% of Americans. A subset of these patients (~20%) with steatotic liver disease progress to an inflammatory fibrotic condition known as metabolic…
account_circle
MountSinaiLiver(@MountSinaiLiver) 's Twitter Profile Photo

What is ? Dr. Meena Bansal has the answers. Learn more about condition that's impacting many. Ready to take action? Reach out to schedule your appointment at 212-241-7270.
Mount Sinai Department of Medicine

account_circle
MountSinaiLiver(@MountSinaiLiver) 's Twitter Profile Photo

Is reversible? Dr. Meena Bansal has the answers! Learn more about this common condition that's impacting so many. Ready to take action? Reach out to schedule your appointment at 212-241-7270. Mount Sinai Department of Medicine

account_circle